# A Study of Mavorixafor in Participants With Congenital Neutropenia and Chronic Idiopathic Neutropenia Disorders

> **NCT04154488** · PHASE1,PHASE2 · COMPLETED · sponsor: **X4 Pharmaceuticals** · enrollment: 32 (actual)

## Conditions studied

- Neutropenia

## Interventions

- **DRUG:** Mavorixafor

## Key facts

- **NCT ID:** NCT04154488
- **Lead sponsor:** X4 Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-16
- **Primary completion:** 2024-08-27
- **Final completion:** 2024-08-27
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04154488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04154488, "A Study of Mavorixafor in Participants With Congenital Neutropenia and Chronic Idiopathic Neutropenia Disorders". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04154488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*